?? How Long Can You Live With Lung Cancer Without Treatment? Lung cancer is one of the deadliest cancers worldwide, and without treatment, survival rates drop significantly: ?? Small Cell Lung Cancer (SCLC): Median survival of 2-4 months ?? Non-Small Cell Lung Cancer (NSCLC): Median survival of 11.9 months ?? The good news? Early detection and treatment can dramatically improve survival. ?? Innovative testing, like the CIZ1B Biomarker Test, is changing the landscape of lung cancer diagnosis—offering a non-invasive way to detect cancer earlier and increase treatment success. Read our latest article to learn about survival timelines, the impact of early diagnosis, and why treatment is crucial. ?? Read more:?https://lnkd.in/gVFiF3uM #LungCancer #CancerResearch #EarlyDetection #CizzleBio #LungHealth #Oncology #HealthcareInnovation American Society of Clinical Oncology (ASCO) Conquer Cancer, the ASCO Foundation OncoDaily
关于我们
Cizzle Bio, Inc. is at the forefront of biotechnological innovation, dedicated to revolutionizing lung cancer detection through our pioneering CIZ1B biomarker blood test. Our mission is to improve early-stage lung cancer diagnosis, enhancing patient outcomes with non-invasive, highly accurate diagnostic solutions. In collaboration with Cizzle Biotechnology PLC, we utilize patented technologies to offer an effective alternative to traditional screening methods. With a focus on continuous innovation, strategic partnerships, and patient-centered care, we aim to make early cancer detection accessible and reliable for all.
- 网站
-
https://www.cizzlebio.com
Cizzle Bio, Inc.的外部链接
- 所属行业
- 生物技术研究
- 规模
- 2-10 人
- 总部
- San Antonio,TX
- 类型
- 私人持股
- 领域
- Lung Cancer Detection、Biomarker Research、Early Cancer Diagnosis、Non-Invasive Diagnostics和Biotechnology Innovation
地点
-
主要
US,TX,San Antonio,78248
Cizzle Bio, Inc.员工
-
Yolanda Heiberger, M.A.
Experienced Medical/Healthcare Communications Professional
-
Bill Behnke
CEO @ Cizzle Bio | CEO @ The Behnke Group
-
Mary Jimenez
Top 25 Healthcare Technology Leaders of San Antonio Innovation| Strategy | Leadership | Sales | Market Access
-
Abisai Kuok
CEO of The Virtual Design Company | Director of Web & IT @ Cizzle Bio
动态
-
A huge thank you to everyone who participated in yesterday's meeting! Your insights, expertise, and collaboration are invaluable as we continue our work at Cizzle Bio to advance early cancer detection. We appreciate the time and effort each of you brings to the table, and we look forward to what’s ahead! #EarlyCancerDetection #CizzleBio?#CancerResearch #OncologyLeadership Bill Behnke, Ron Greeno MD, MHM, FCCP, Rosen Steven, William Dalton, Joseph Kelley, Mary Jimenez, Steve Henderson, Ph.D., Anthony Voorhies, Jennifer Hinkel MSc CHW FRSA, Yolanda Heiberger, M.A., Virginia Manzo, Daniela Kuok, Abisai Kuok
-
Great to see OncoDaily sharing the news of Dr. Greeno joining Cizzle Bio! Ron Greeno MD, MHM, FCCP shared his thoughts on this exciting new role: "I am excited to be part of the excellent team that Cizzle Bio has put together to bring this exciting advancement to the U.S. market.?My entire career, clinicians have been handicapped by the lack of a tool to screen for early-stage lung cancer, and Cizzle Bio’s goal is to fill that void." #LungCancerAwareness #EarlyDetection #HealthcareInnovation #CizzleBio Check out OncoDaily’s original post here ??
Cizzle Bio announced Dr. Ron Greeno as its new Chief Medical Officer Cizzle Bio, Inc. appointed Dr. Ron Greeno MD, MHM, FCCP as its new Chief Medical Officer, bringing 30 years of experience in healthcare leadership, clinical strategy, and policy development to support the company’s mission in advancing early cancer detection. https://lnkd.in/ep2rmMHn #HealthcareLeadership #ClinicalStrategy #Cancer #OncoDaily #Medicine #Oncology
-
-
???Exciting Leadership News!??? We are thrilled to welcome?Ron Greeno MD, MHM, FCCP?to?Cizzle Bio, Inc. as our new?Chief Medical Officer! With over?30 years of experience?in?healthcare strategy, clinical leadership, and policy innovation, Dr. Greeno’s expertise will help drive our mission to?revolutionize early cancer detection. As a?recognized leader in healthcare policy and physician services, Dr. Greeno’s strategic vision will be instrumental in?advancing biomarker-driven diagnostics?and enhancing?patient access to cutting-edge technologies. Please join us in welcoming Dr. Greeno to the Cizzle Bio team! ?? Read more:?https://lnkd.in/gKk2eaks #HealthcareLeadership #EarlyCancerDetection #Biotech #CizzleBio #CancerResearch Sound Physicians TeamHealth Society of Hospital Medicine OncoDaily Centers for Medicare & Medicaid Services LUNGevity Foundation Prevent Cancer Foundation American Cancer Society American Society of Clinical Oncology (ASCO) Conquer Cancer, the ASCO Foundation American Association for Cancer Research
-
Knowledge is power when it comes to cancer prevention! ???? During?#CancerPreventionMonth, we’re aligning with?Conquer Cancer, the ASCO Foundation to spread awareness and education. Did you know that?tobacco use?is the single biggest preventable cause of cancer? Smoking alone causes about?20% of all cancersand?30% of cancer deaths?in the U.S. At?Cizzle Bio, Inc., our mission is to?Detect Early. Save Lives.?But prevention is the first line of defense. Take the quiz, learn more, and share this with your network—because awareness can save lives! #CancerAwareness #EarlyDetection #PreventCancer
This #CancerPreventionMonth, we're testing your cancer prevention knowledge! Think you can get all the questions correct? Take the full quiz to find out! https://brnw.ch/21wQSNS
-
Cizzle Bio, Inc. Welcomes Jennifer Hinkel! We are excited to introduce Jennifer Hinkel MSc CHW FRSA, as our Senior Consultant, Economics & Commercialization at Cizzle Bio! With 15+ years of experience in health economics, market access, and oncology commercialization, Jennifer has guided leading biopharma and medtech companies through payer engagement, global market expansion, and regulatory landscapes. Her leadership at Genentech, Caris Life Sciences, and McGivney Global Advisors has helped bring innovative healthcare solutions to patients worldwide. As a cancer survivor and patient advocate, Jennifer is passionate about ensuring life-saving diagnostics reach those who need them most. We are excited to have Jennifer on board as we continue expanding access to biomarker-based cancer diagnostics worldwide! ?? Read more: https://lnkd.in/gZAQpg8K #CancerResearch #MarketAccess #Oncology #EarlyDetection #Biotech #HealthEconomics
-
?? Cizzle Bio, Inc. is proud to attend the?2025 ASCO Annual Meeting, the premier event for oncology professionals! ?? From?May 30 – June 3, 2025, at?McCormick Place, Chicago, we’ll engage with leading researchers, clinicians, and advocates to drive advancements in cancer care. Our team looks forward to discussing early detection’s vital role in improving patient outcomes. Let’s connect and explore opportunities to collaborate! ?? ?? Learn more:?https://lnkd.in/gRy5zaia #ASCO25 #Oncology #CancerResearch #EarlyDetection #CizzleBio #HealthcareInnovation American Society of Clinical Oncology (ASCO) Conquer Cancer, the ASCO Foundation
-
???Cizzle Bio welcomes Yolanda Heiberger as Vice President of Communications & Patient Education! With extensive experience in?healthcare communications, patient education, and strategic messaging, Yolanda will play a key role in shaping how we engage with?patients, physicians, and the broader medical community?in our mission to revolutionize?early cancer detection. She has led initiatives for?biotech companies, academic medical centers, and research institutions, including?Cardinal Health, UAB Heersink School of Medicine, HudsonAlpha Institute for Biotechnology, and the Leukemia & Lymphoma Society. Her ability to?simplify complex scientific concepts and drive impactful patient engagementmakes her an invaluable addition to?Cizzle Bio’s leadership team. ???Bill Behnke, Cizzle Bio’s Chairman & CEO, shared: “I have known Yolanda for several years; she has helped me with writing and PR for other startups I have been involved with, and we are thrilled to have her join the Cizzle team!” Join us in welcoming Yolanda as we continue to?advance patient education and awareness in early cancer detection. ???Read more:?https://lnkd.in/gJchFTvg #CizzleBio #CancerAwareness #HealthcareCommunications #EarlyDetection #BiotechInnovation American Society of Clinical Oncology (ASCO) American Association for Cancer Research Conquer Cancer, the ASCO Foundation Cardinal Health The Leukemia & Lymphoma Society HudsonAlpha Institute for Biotechnology
-
Cizzle Bio, Inc. is attending the AACR Annual Meeting 2025! We’re excited to be in Chicago from April 25-30 for one of the most important gatherings in cancer research and innovation. This event brings together leading scientists, clinicians, and industry experts to explore the latest advancements in oncology, early detection, and precision medicine. If you’re attending, let’s connect and discuss how we can advance early cancer detection together! ?? McCormick Place Convention Center, Chicago, IL ?? Read more:?https://lnkd.in/gAd-xz6F #AACR25 #CancerResearch #Oncology #Biomarkers #EarlyDetection #CizzleBio #MedicalInnovation American Association for Cancer Research